JPMorgan analysts see tough road ahead for Humana if Aetna deal blocked
July 08, 2016 at 13:34 PM EDT
JPMorgan analysts slashed the target price of Humana from $196 to $150 after reports the DOJ may block the acquisition by Aetna.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|